KLRS
Kalaris Therapeutics, Inc.
2.80$
+4.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | – | – | – | |
| 149.8% | 9,835.8% | – | – | – | – | – | – | |
| 416.8% | 16,270.9% | – | – | – | – | – | – | |
| -316.8% | -16,182.4% | – | – | – | – | – | – | |
| -214.1% | -14,447.9% | – | – | – | – | – | – | |
| -214.1% | -14,447.9% | – | – | – | – | – | – | |
| -214.1% | -14,436.4% | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.